BHC News and Press, Bausch Health Companies Inc. From 02/18/26

2026-02-18 15:59:32 ET More on Bausch Health Companies Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Bausch Health Companies Inc. (BHC) Presents...

OGE Energy Corp (OGE) is expected to report $0.3 for Q4 2025 Dana Incorporated (DAN) is expected to report $0.32 for Q4 2025 SiriusPoint Ltd. (SPNT) is expected to report $0.54 for Q4 2025 Nutrien Ltd. (NTR) is expected to report $0.82 for Q4 2025 Broadstone Net Lease Inc. (BNL) i...

2026-02-17 17:43:50 ET More on 13F filings Tiger Global takes new stakes in WLTH, trims NVDA, AMZN, and MSFT among Q4 moves SoftBank adds TwentyOne Capital, exits Nvidia, boosts eToro stake among top Q4 trades Baupost adds Amazon, exits PagSeguro, boosts UNP stake, a...

2026-02-17 17:35:32 ET More on Bausch Health Companies Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Bausch Health Companies Inc. (BHC) Presents...

2026-02-15 08:07:25 ET Despite a holiday-shortened week, earnings season rolls on with another eventful slate ahead, as a diverse mix of consumer, energy, technology, healthcare, financial, and materials companies step into the spotlight.... Read the full article on Seeking Alpha ...

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program PR Newswire Bausch Health to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC , Feb. 11, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology ...

2026-02-03 23:20:00 ET Bausch Health Companies (NYSE: BHC) shares have struggled for many year, and 2026 is not currently off to a good start. Since the start of the year, Bausch Health has fallen by 17%. There are several substantive reasons behind this pullback. For one, the p...

2026-01-23 14:35:21 ET Bausch Health Companies Inc. ( BHC ) stock is off nearly 10% in intraday trading after reporting that its Phase 3 program evaluating "next-gen" rifaximin to delay the first episode of hepatic encephalopathy in patients with cirrhosis failed.... R...

2026-01-23 08:55:07 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bausch Health C...

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials Canada NewsWire LAVAL, QC , Jan. 23, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 RED-C clinical program evaluating amorphous-rifaximin sol...